Recombinant multi-species KRTAP1-1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KRTAP1-1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This protein is a member of the keratin-associated protein (KAP) family. The KAP proteins form a matrix of keratin intermediate filaments which contribute to the structure of hair fibers. KAP family members appear to have unique, family-specific amino- and carboxyl-terminal regions and are subdivided into three multi-gene families according to amino acid composition: the high sulfur, the ultrahigh sulfur, and the high tyrosine/glycine KAPs. This protein is a member of the high sulfur KAP family and the gene is localized to a cluster of KAPs at 17q12-q21. [provided by RefSeq, Jul 2008]
The Alternative Names of target: HB2A,High sulfur keratin-associated protein 1.1,KAP1.1,KAP1.1A,KAP1.1B,KAP1.6,KAP1.7,KRTAP1-1,KRTAP1.1,KRTAP1A,Keratin-associated protein 1-1,Keratin-associated protein 1.1,Keratin-associated protein 1.6,Keratin-associated protein 1.7,hKAP1.7

Target products collectionGo to KRTAP1-1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12579-Ag-1/ GM-Tg-hg-IP12579-Ag-2 Human KRTAP1-1 protein Human
GM-Tg-rg-IP12579-Ag-1/ GM-Tg-rg-IP12579-Ag-2 Rat KRTAP1-1 protein Rat
GM-Tg-mg-IP12579-Ag-1/ GM-Tg-mg-IP12579-Ag-2 Mouse KRTAP1-1 protein Mouse
GM-Tg-cynog-IP12579-Ag-1/ GM-Tg-cynog-IP12579-Ag-2 Cynomolgus/Rhesus macaque KRTAP1-1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12579-Ag-1/ GM-Tg-felg-IP12579-Ag-2 Feline KRTAP1-1 protein Feline
GM-Tg-cang-IP12579-Ag-1/ GM-Tg-cang-IP12579-Ag-2 Canine KRTAP1-1 protein Canine
GM-Tg-bovg-IP12579-Ag-1/ GM-Tg-bovg-IP12579-Ag-2 Bovine KRTAP1-1 protein Bovine
GM-Tg-equg-IP12579-Ag-1/ GM-Tg-equg-IP12579-Ag-2 Equine KRTAP1-1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12579-Ag-1/ GM-Tg-hg-IP12579-Ag-2; GM-Tg-rg-IP12579-Ag-1/ GM-Tg-rg-IP12579-Ag-2;
GM-Tg-mg-IP12579-Ag-1/ GM-Tg-mg-IP12579-Ag-2; GM-Tg-cynog-IP12579-Ag-1/ GM-Tg-cynog-IP12579-Ag-2;
GM-Tg-felg-IP12579-Ag-1/ GM-Tg-felg-IP12579-Ag-2; GM-Tg-cang-IP12579-Ag-1/ GM-Tg-cang-IP12579-Ag-2;
GM-Tg-bovg-IP12579-Ag-1/ GM-Tg-bovg-IP12579-Ag-2; GM-Tg-equg-IP12579-Ag-1/ GM-Tg-equg-IP12579-Ag-2
Products Name KRTAP1-1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name KRTAP1-1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KRTAP1-1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.